Benjamin Liang
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 11
- Viral gastroenteritis research and epidemiology 1
- SARS-CoV-2 detection and testing 1
-
- Animal Virus Infections Studies 4
- Co-authors
- Daniel Watterson (10 shared papers)Naphak Modhiran (10 shared papers)Alexander A. Khromykh (7 shared papers)Alberto Anastacio Amarilla (8 shared papers)Stacey T. M. Cheung (4 shared papers)Paul R. Young (7 shared papers)Christopher L. D. McMillan (3 shared papers)Keith Joseph Chappell (4 shared papers)
- Journals
- Nature Communications (3 papers)Vaccines (2 papers)Frontiers in Microbiology (1 paper)Science Advances (1 paper)Pharmaceutics (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Benjamin Liang
18 papers receiving 546 citations
Peers
Comparison fields: 5 of 56
- Infectious Diseases 235
- Aging 11
- Animal Science and Zoology 50
- Neurology 70
- Pharmaceutical Science 33
Countries citing papers authored by Benjamin Liang
This map shows the geographic impact of Benjamin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Liang more than expected).
Fields of papers citing papers by Benjamin Liang
This network shows the impact of papers produced by Benjamin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Liang. The network helps show where Benjamin Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 142 | |
| 2 | 2021 | 115 | |
| 3 | 2023 | 59 | |
| 4 | 2021 | 46 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 32 | |
| 7 | 2016 | 24 | |
| 8 | 2023 | 21 | |
| 9 | 2017 | 19 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 0 |
About Benjamin Liang
Benjamin Liang is a scholar working on Infectious Diseases, Animal Science and Zoology, Pharmaceutical Science, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 19 papers that have together received 552 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), Animal Virus Infections Studies (4 papers), Inflammasome and immune disorders (1 paper), Viral gastroenteritis research and epidemiology (1 paper), Mosquito-borne diseases and control (1 paper), Organic Chemistry Synthesis Methods (1 paper), Advancements in Transdermal Drug Delivery (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Infectious Diseases (235 citations), Aging (11 citations), Animal Science and Zoology (50 citations), Neurology (70 citations) and Pharmaceutical Science (33 citations). Benjamin Liang has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Daniel Watterson, Naphak Modhiran, Alexander A. Khromykh, Alberto Anastacio Amarilla, Stacey T. M. Cheung, Paul R. Young, Christopher L. D. McMillan, Keith Joseph Chappell, Nias Y. G. Peng and Dolyce H. W. Low. Their work appears in journals such as Nature Communications, Vaccines, Frontiers in Microbiology, Science Advances and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.